Prospects for new drugs and regimens in the treatment of tuberculosis
Since rifampicin was introduced in 1967, no novel compounds have been approved for first-line chemotherapy of tuberculosis.The inexorable rise in cases of tuberculosis worldwide, fuelled by the HIV epidemic, highlights the need for new drugs, particularly those that can shorten the duration of treat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Journal |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=57049166987&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/60559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Chiang Mai University |